KUALA LUMPUR, May 16 – The newly enforced medicine price display rule, which came into effect on May 1, has been praised by consumer groups as a significant step toward curbing excessive mark-ups and empowering patients with pricing transparency. Under the Price Control and Anti-Profiteering (Price Labelling for Medicines) Order 2025, private clinics, hospitals, and pharmacies must now display prices for all medications, including prescription drugs, supplements, and traditional remedies.
Advocates say this will help consumers make informed choices, manage their healthcare costs, and address decades of price opacity in the private health sector. Consumer organisations and health policy experts have applauded the initiative as a milestone in consumer rights, but also emphasised the importance of enforcement following a three-month grace period.
While some concerns were raised over alleged enforcement threats, the Ministry of Domestic Trade and the Health Ministry clarified that no punitive action will be taken during the awareness phase. As Malaysia moves forward with this policy, stakeholders stress that transparent pricing is not about controlling doctors’ fees but about empowering the public with fair access to essential medicines.
